EU Clinical Trial Portal Requires Rethink On Balancing Business Interests & Transparency
Sponsors Can Defer Publication Of Certain Data
Executive Summary
In the first of a two-part article on transparency provisions for the new EU clinical trial portal, the Pink Sheet reports on aspects that sponsors must consider to protect commercially confidential information in their clinical trial applications. The second article will look at the approach taken by Merck and discuss outstanding hot topics in relation to transparency and CTIS.